Topiramate for juvenile myoclonic epilepsy

Source:
Cochrane Database of Systematic Reviews
Publisher:
Cochrane Database of Systematic Reviews
Publication date:
28 January 2019

Abstract

Weak evidence from 3 RCTs (n=83) at high risk of bias does not support topiramate for the treatment of people with juvenile myoclonic epilepsy.